CAS RN: 1038915-73-9

MK-4827 (tosylate)

Product Availability

Choose a grade to view its available package options.

9 package records8 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260422 100mg In stock Shanghai Inquiry
Batchno.20250125 1g In stock Shanghai, Shenzhen Inquiry
Batchno.20250302 1mg In stock Shanghai Inquiry
Batchno.20251122 250mg In stock Shanghai Inquiry
Batchno.20250328 2mg In stock Shanghai Inquiry
Batchno.20251130 50mg In stock Shanghai Inquiry
Batchno.20260216 5g In stock Shanghai Inquiry
Batchno.20260126 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250722 5mg / 25mg / 100mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS1038915-73-9
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1038915-73-9 / 4-methylbenzenesulfonic acid;2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide

Niraparib tosylate | MK-4827 tosylate | MK-4827-tosylate

Standard CAS: 1038915-73-9 Multi CAS: Yes

Basic Information

CAS
1038915-73-9
Multi CAS
Yes
Molecular Formula
C26H28N4O4S
Molecular Weight
492.600000
Exact Mass
492.183127
SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N
InChI
InChI=1S/C19H20N4O.C7H8O3S/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14;1-6-2-4-7(5-3-6)11(8,9)10/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24);2-5H,1H3,(H,8,9,10)/t14-;/m1./s1
InChIKey
LCPFHXWLJMNKNC-PFEQFJNWSA-N
Synonyms
Niraparib tosylate MK-4827 tosylate MK-4827-tosylate 75KE12AY9U DTXSID801026487

Computed Properties

Structural Parameters

Heavy atom count
35
Aromatic heavy atom count
21
Fraction Csp3
0.23
Rotatable bonds
4
H-bond acceptors
6
H-bond donors
3
Molar refractivity
135.43
TPSA
127.31

LogP / Solubility

WLOGP
3.83
MLOGP
3.41
XLogP3
3.83
Consensus LogP
3.69
Log S (ESOL)
-5.49
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.37
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-6.52
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
4

Get In Touch

Contact Us